XMGFGS(300967)
Search documents
晓鸣股份(300967) - 2021 Q2 - 季度财报
2021-08-17 16:00
Financial Performance - The company's operating revenue for the first half of 2021 was CNY 354,267,032.13, representing a 26.12% increase compared to CNY 280,888,542.76 in the same period last year[22]. - The net profit attributable to shareholders of the listed company reached CNY 51,951,316.04, a significant increase of 61.23% from CNY 32,222,123.42 in the previous year[22]. - The net cash flow from operating activities was CNY 91,004,778.55, which is a remarkable increase of 210.74% compared to CNY 29,286,696.49 in the same period last year[22]. - The basic earnings per share increased to CNY 0.33, up 43.48% from CNY 0.23 in the previous year[22]. - Total assets at the end of the reporting period were CNY 1,074,650,586.41, reflecting a 22.90% increase from CNY 874,431,397.93 at the end of the previous year[22]. - The net assets attributable to shareholders of the listed company increased to CNY 795,473,822.06, a 29.35% rise from CNY 614,970,972.76 at the end of the previous year[22]. - The weighted average return on net assets was 7.53%, an increase of 1.98% compared to 5.55% in the previous year[22]. - The net profit after deducting non-recurring gains and losses was CNY 43,317,905.63, which is a 29.35% increase from CNY 33,489,372.93 in the same period last year[22]. Business Operations - The main business involves breeding and selling parent and grandparent generation egg-laying chickens, with a focus on technology development and service[28]. - The company operates three high-standard ecological breeding bases and has established 7 breeding divisions and 5 hatcheries across various regions[28]. - The procurement of grandparent generation chicks is conducted through a long-term strategic partnership with a global breeding company, ensuring a stable supply[32]. - The production model includes independent breeding and hatching processes, with a focus on biosecurity and product quality through a "full network high bed flat breeding" approach[30]. - The company employs a direct sales and distribution model, providing technical guidance and services to customers to enhance product promotion[30]. - The feed production is managed in-house, with a focus on controlling procurement risks and ensuring product quality through centralized bidding[33]. - The company has implemented a comprehensive internal control system for procurement and production management to enhance operational efficiency[33]. - The production process includes a detailed plan for egg allocation and hatching, ensuring a streamlined supply chain for chick production[35]. Market and Industry Trends - In 2021, China's poultry egg production decreased by 4.1% year-on-year to 15.57 million tons, with egg prices increasing by 9.3%[46]. - The number of breeding hens in China is expected to remain at around 15 million sets for parent stock, with an estimated 1.1 to 1.2 billion commercial layer chicks added in 2021[47]. - The introduction of the National Egg Chicken Genetic Improvement Plan (2021-2035) aims to establish a commercial breeding system by 2035, enhancing breeding technology to international advanced levels[47]. - The egg chicken breeding industry in China is characterized by a low overall concentration, with approximately 700 single-generation breeding enterprises, which are gradually decreasing[50]. - Major retailers and food companies in Europe are committing to sourcing only cage-free eggs by 2027, reflecting a significant shift in consumer preferences and regulatory changes[45]. - The EU has mandated the elimination of cage farming for egg-laying hens by 2027, responding to consumer demands for animal welfare and food quality[45]. - The overall profitability of egg chicken farming in China was negative in 2020 due to high feed costs and oversupply, impacting the willingness of small-scale farmers to enter the market[46]. - The egg chicken industry is transitioning from quantity growth to quality and efficiency, supported by national policies and structural reforms in agriculture[51]. Research and Development - Two key R&D projects were initiated under the Ningxia Hui Autonomous Region's key R&D plan, and two invention patents were applied for[39]. - The company has established a robust biosecurity system, with no major infectious diseases reported since its inception, enhancing its disease prevention capabilities[82]. - The company has built a strong R&D team focused on egg chicken breeding technology, with a comprehensive technical support system in place[88]. - The company has developed core technologies in breeding, hatching, and feed formulation, enhancing its competitive edge in the market[91]. - The company has established effective customer feedback mechanisms to address quality disputes and improve service quality[86]. Financial Management - Operating costs rose to ¥245,983,467.65, a 28.87% increase compared to the previous year, primarily driven by higher sales volume[107]. - Research and development expenses decreased by 19.67% to ¥9,708,047.73, as some projects were initiated later in the year[108]. - The company's cash and cash equivalents increased significantly by 16,510.85% to ¥157,482,968.56, mainly due to new share issuance[108]. - The total amount of funds raised was ¥147,302,133.26, with ¥35,105,941.43 invested during the reporting period[114]. - The company's gross profit margin for chicken sales was 30.37%, a decrease of 2.97% compared to the previous year[109]. Risks and Challenges - The company faces several risks, including poultry disease risks and reliance on foreign suppliers for egg-laying chickens[6]. - The company faces significant risks from avian diseases, which could severely impact production and operational performance[128]. - Fluctuations in raw material prices, particularly corn and soybean meal, could lead to increased production costs and decreased profit margins[129]. - The chicken egg market is subject to frequent price volatility due to macroeconomic factors, seasonal changes, and public health events[130]. - Dependency on foreign suppliers for high-quality breeding stock poses a risk, particularly with reliance on a single supplier, Aviagen[132]. - The COVID-19 pandemic has adversely affected operations, leading to transportation issues and decreased consumer demand for poultry products[133]. Corporate Governance and Social Responsibility - The company has actively participated in social responsibility initiatives, contributing a total of CNY 1.0497 million to poverty alleviation and rural revitalization efforts[152]. - The company has established a regular monitoring plan for environmental pollutants and has ensured compliance with emission standards through third-party assessments[150]. - The company has maintained a good integrity status, with no administrative or criminal penalties imposed during the reporting period[163]. - The company has not engaged in any non-operating fund occupation by controlling shareholders or related parties during the reporting period[156]. - The company has not reported any significant changes in its financial situation or major risks during the reporting period[179].
晓鸣股份(300967) - 2021 Q1 - 季度财报
2021-04-28 16:00
Financial Performance - The company's revenue for Q1 2021 was CNY 147,696,606.23, representing a 13.77% increase compared to CNY 129,821,493.01 in the same period last year[10]. - Net profit attributable to shareholders was CNY 17,322,243.33, a 2.00% increase from CNY 16,982,369.37 year-on-year[10]. - The net profit after deducting non-recurring gains and losses decreased by 48.12% to CNY 9,802,533.47 from CNY 18,894,533.08 in the previous year[10]. - The net cash flow from operating activities increased significantly by 147.38% to CNY 30,670,533.72 compared to CNY 12,397,971.91 in the same period last year[10]. - Total operating revenue for Q1 2021 was CNY 147,696,606.23, an increase of 13.6% compared to CNY 129,821,493.01 in the same period last year[55]. - Total operating costs for Q1 2021 were CNY 137,894,180.78, up 24.5% from CNY 110,746,915.07 in Q1 2020[56]. - The total comprehensive income for the first quarter of 2021 was CNY 18,220,738.90, compared to CNY 16,193,060.25 in the same period of 2020, representing an increase of approximately 12.5%[62]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 913,741,476.78, up 4.50% from CNY 874,431,397.93 at the end of the previous year[10]. - Total liabilities amounted to CNY 281,448,260.69 as of March 31, 2021, compared to CNY 259,460,425.17 at the end of 2020, reflecting a rise of about 8.5%[49]. - The company's retained earnings increased to ¥283,757,618.45 as of March 31, 2021, compared to ¥266,435,375.12 at the end of 2020, representing a growth of approximately 6.5%[50]. - The total equity attributable to shareholders rose to ¥632,293,216.09 as of March 31, 2021, up from ¥614,970,972.76 at the end of 2020, indicating an increase of about 2.0%[50]. - Current assets increased to ¥157,818,467.39 as of March 31, 2021, up from ¥130,327,543.12 on December 31, 2020, representing a growth of approximately 20.9%[47]. - Total liabilities as of Q1 2021 amounted to CNY 297,636,428.35, an increase from CNY 279,152,105.51 in the previous year[56]. Research and Development - The company is investing 8 million yuan in independent R&D projects focused on standardized chicken farming and nutrition technology[23]. - The company invested a total of 800.00 million CNY in independent research projects related to egg production and waste management[24]. - The company is developing a fine breeding and health management technology for the American Hy-Line egg-laying chicken, focusing on performance data collection and welfare-based feeding models[26]. - The company is conducting research on the effective utilization of chicken waste and its safe application in agriculture[24]. - The company invested 622.00 million CNY in the development of key breeding technologies for high-yield egg-laying chickens, focusing on the application of precision breeding techniques in the western region of China[27]. - The company emphasizes the importance of technology innovation, with a commitment to increasing R&D funding to enhance product quality and meet market demands[28]. Market and Operational Strategy - The company plans to invest raised funds into multiple projects, including the Alashan million chicken ecological breeding base and the egg chicken industry research institute[37]. - The company aims to enhance its core competitiveness through management and technological innovations, focusing on standardized management and production efficiency[37]. - The company is focused on expanding its market presence and diversifying its product offerings to mitigate market risks[37]. - The company has established partnerships with institutions like Shanghai Academy of Agricultural Sciences and Ningxia University to foster talent and improve technical capabilities[28]. - The company reported that the domestic egg consumption market is significantly influenced by macroeconomic factors, seasonal changes, and public health events, leading to price volatility[33]. Risks and Challenges - The company faces significant risks from avian diseases, which could severely impact production performance and lead to increased operational costs due to vaccination and emergency measures[30]. - Fluctuations in raw material prices, particularly corn and soybean meal, pose a risk to the company's production costs and overall profitability[31]. - The company has a diversified supplier system, with frequent changes among the top five suppliers to enhance supply chain resilience[29]. - The company maintains a broad customer base, leading to significant variability in the top five customers over time[29]. - The company has taken proactive measures to respond to the challenges posed by the COVID-19 pandemic, although its 2020 operating performance was still negatively impacted[34]. Cash Flow and Investments - Cash inflow from operating activities totaled CNY 163,631,179.53, up from CNY 133,236,805.18, indicating a growth of approximately 22.8%[65]. - The net cash flow from financing activities was negative at CNY -2,488,319.85, compared to a positive CNY 22,439,715.58 in the same period last year[69]. - The ending balance of cash and cash equivalents increased to CNY 51,019,767.82 from CNY 33,750,451.05, representing a growth of about 51.1%[66]. - The company reported a total cash inflow from sales of goods and services of CNY 154,737,012.47, compared to CNY 132,029,463.72 in the previous year, an increase of approximately 16.3%[64]. Lease Agreements and Accounting Adjustments - The company has ongoing lease agreements with various entities, including a contract with Shaanxi Chia Tai Co., Ltd. for a hatchery facility valid until September 30, 2023[78]. - The company executed adjustments in accounting standards, increasing "right-of-use assets" by CNY 27,937,987.31 and decreasing "long-term prepaid expenses" by CNY 5,157,338.56[75]. - The "Lease Liabilities" account increased by CNY 21,145,180.35 following the adoption of the new leasing standards[79].
晓鸣股份(300967) - 2020 Q4 - 年度财报
2021-04-28 16:00
Financial Performance - In 2020, the company achieved a sales revenue of 540.02 million yuan, a year-on-year increase of 0.11%[6]. - The net profit attributable to shareholders was 50.25 million yuan, a year-on-year decrease of 54.91%[6]. - The company's revenue for 2020 was approximately ¥540 million, a slight increase of 0.11% compared to ¥539 million in 2019[29]. - Net profit attributable to shareholders decreased by 54.91% to approximately ¥50 million from ¥111 million in 2019[29]. - The net cash flow from operating activities fell by 54.33% to approximately ¥85 million, down from ¥186 million in 2019[29]. - Basic earnings per share dropped by 54.43% to ¥0.36 from ¥0.79 in the previous year[29]. - Total assets increased by 12.87% to approximately ¥874 million at the end of 2020, compared to ¥775 million at the end of 2019[29]. - The company's net assets attributable to shareholders rose by 8.90% to approximately ¥615 million from ¥565 million in 2019[29]. - Total revenue for the year was approximately 541 million RMB, with a quarterly breakdown showing Q1 at 129.82 million RMB, Q2 at 151.07 million RMB, Q3 at 145.73 million RMB, and Q4 at 113.40 million RMB[32]. - Net profit attributable to shareholders for the year was approximately 50 million RMB, with Q1 at 16.98 million RMB, Q2 at 15.24 million RMB, Q3 at 17.98 million RMB, and a significant drop in Q4 to 0.05 million RMB[32]. Market and Industry Trends - The company reported that the poultry industry is undergoing a transformation, with no severe overcapacity or continuous decline observed[6]. - The egg production industry in China has completed the transformation towards good breed, specialization, facility-based, and market-oriented operations, forming a relatively complete division of labor system[57]. - The egg industry in China is experiencing a shift towards large-scale modern integrated production enterprises, driven by environmental regulations and food safety standards[58]. - The overall supply capacity of the egg industry is primarily determined by the scale of grandparent breeding, while demand is influenced by the consumption market and processing industry[56]. - The industry is transitioning from quantity growth to quality and efficiency, driven by government policies and structural reforms[70]. - The number of small-scale chicken farms (under 100,000 birds) accounts for 99.4% of the total, indicating a highly fragmented market[72]. - The company has established a comprehensive internal control system for procurement and production management[43]. Operational Strategies - The company maintained growth in its main business and market share despite the challenges, focusing on high-quality development and cost control[6]. - The company aims to enhance its core competitiveness through management and technological innovations, focusing on standardized management and production efficiency[17]. - The company has established a robust biosecurity system, with no major infectious diseases reported since its inception[103]. - The company employs advanced single-stage incubation technology, improving overall hatching rates and chick health rates[81]. - The company utilizes a "centralized breeding, decentralized hatching" model to optimize production costs and efficiency[105]. - The company has established advanced production facilities, including a modern breeding farm equipped with precise environmental control systems and state-of-the-art incubation technology[107]. - The company has built a strong technical research and development team, focusing on feed nutrition, disease control, and automated breeding technologies[109]. Research and Development - The company is committed to increasing R&D investment to improve biosecurity and disease prevention technologies[17]. - The company has invested a total of 800,000 RMB in three independent R&D projects focused on precision nutrition and feed technology for layer chickens[151]. - The R&D team is structured into specialized centers focusing on disease control, nutrition, and environmental monitoring, enhancing operational efficiency[121]. - The company has applied for several patents related to feed formulation and preparation methods, indicating ongoing innovation in product development[120]. - The company aims to establish a comprehensive disease prevention and purification system for five major poultry diseases, enhancing overall flock health and reducing vaccination costs[153]. Financial Management and Investments - The company plans to invest raised funds into multiple projects, including ecological breeding bases and a research institute, which may face implementation risks[16]. - The company has implemented a comprehensive financial and operational management system, integrating various business functions to enhance efficiency[107]. - The company has received government subsidies amounting to approximately 7.11 million RMB in 2020, an increase from 5.57 million RMB in 2019[35]. - The company has maintained a consistent cash dividend policy, with no adjustments made during the reporting period[180]. - The company proposed a cash dividend of CNY 1.00 per share (before tax), totaling CNY 18,750,600.00 for the year 2020[180]. Challenges and Risks - The company faced significant impacts from the COVID-19 pandemic, affecting product transportation and leading to customer order cancellations[12]. - The company highlighted risks related to price fluctuations of raw materials, particularly corn and soybean meal, which could adversely affect operating performance[8]. - The profit level in the egg-laying industry is highly volatile, influenced by factors such as livestock capacity adjustments, egg price fluctuations, feed costs, and rising labor and environmental costs[73]. Future Outlook - The company has set a performance guidance for 2021, projecting a revenue increase of 20% to CNY 1.44 billion[188]. - The company plans to enhance brand awareness through advertising, media coverage, and public relations activities, aiming to create more regional famous brands and strive for national famous trademarks[172]. - The company aims to improve operational efficiency, targeting a reduction in costs by 8% through process optimization[193]. - The company is considering strategic acquisitions to enhance its market position, with a budget of CNY 200 million earmarked for potential acquisitions in 2021[188].